Absci Investor Presentation Deck

NOVEL TARGET DISCOVERY The leading Al platform for Al-enabled biologics drug creation Find patient cohort specific targets ↓ Novel target discovery ai. ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Discover novel antibodies for selected target ↓ De novo discovery in silico ai. Optimize antibodies' characteristics ↓ Lead optimization in silico ai. y Incorporate site-specific chemical handles ↓ Bionic SoluPro™ strain OPTIMAL DRUG CANDIDATE absci. 28

View entire presentation